Loading clinical trials...
Loading clinical trials...
A Study on the Safety, Tolerability, and Efficacy of PDR-001 Injection for Bilateral Stereotactic Subthalamic Nucleus (STN) Clearance of α-synuclein
Conditions
Interventions
PDR001
Locations
1
China
Ruijin hospital
Shanghai, Shanghai Municipality, China
Start Date
October 20, 2025
Primary Completion Date
January 31, 2029
Completion Date
December 31, 2029
Last Updated
September 5, 2025
NCT07495462
NCT07013214
NCT07381907
NCT07308795
NCT07284823
NCT06602544
Lead Sponsor
Ruijin Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions